Trial Profile
Phase I Study of Carfilzomib in Combination With Cyclophosphamide and Etoposide for Children With Relapsed or Refractory Solid Tumors and Leukemias
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 08 Sep 2017
Price :
$35
*
At a glance
- Drugs Carfilzomib (Primary) ; Cyclophosphamide (Primary) ; Etoposide (Primary)
- Indications Leukaemia; Solid tumours
- Focus Adverse reactions
- 08 Sep 2017 New trial record